FogPharma, a biotech startup working on treatments for "undruggable" cancers, raised $107 million in a Series C funding round. With the new capital it will continue work on the projects in its pipeline.
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.